Fortress Biotech, Inc. ( FBIO) - Key Metrics
FBIO Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | ? | ? | ? | ? |
| 2025Q3 | $0.65 | $0.21 | -$0.22 | -$0.22 |
| 2025Q2 | $0.61 | $0.58 | -$1.03 | -$1.03 |
| 2025Q1 | $0.50 | -$0.40 | -$0.74 | -$0.74 |
FBIO Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | ? |
| 2025Q3 | 2.84% | 4.31 |
| 2025Q2 | 1.07% | 0.81 |
| 2025Q1 | -1.57% | -0.97 |
FBIO Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | 231.65% | ? |
| 2025Q4 | -12.28% | ? |
| 2025Q3 | -6.06% | 0.16% |
| 2025Q2 | -55.12% | 0.33% |
| 2025Q1 | -47.41% | 0.40% |
FBIO
Price: $2.61
52 week price:
Payout Ratio Range:
Earnings Per Share: 3.23 USD
P/E Ratio: 0.77
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 340489
Ebitda: -32.4 millionMarket Capitalization: 86.7 million